COVERAGE
A ‘ruthless’ competition: As big law becomes more corporate, some firm leaders see pitfalls for profession
October 27, 2025
Read time: 2 min

COVERAGE
October 27, 2025
Read time: 2 min

COVERAGE
October 24, 2025
Read time: 2 min

COVERAGE
October 24, 2025
Read time: 2 min

COVERAGE
October 23, 2025
Read time: 3 min
International law firm McDermott Will & Schulte represented Constellation Brands, Inc. (NYSE: STZ) (Constellation), a leading beverage alcohol company, in connection with its public offering of $500 million aggregate principal amount of 4.950% senior notes due 2035 which closed on October 17, 2025. BofA Securities, Inc., BBVA Securities Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC acted as joint book-running managers of the offering.
The McDermott team was led by Heidi Steele and included Rich Bass, Charles Darantiere, Riley O’Farrell, and Robin Riley.
Read Constellation’s press release.
About Constellation Brands
Constellation Brands is an international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Constellation’s brand portfolio includes Modelo Especial, Corona Extra, Modelo Cheladas, Pacifico, Victoria, The Prisoner Wine Company, Robert Mondavi Winery, Kim Crawford, Schrader Cellars, Lingua Franca, Casa Noble Tequila, and High West Whiskey.
Leading organizations turn to global law firm McDermott Will & Schulte for a better way to address legal challenges, connect with those at the forefront, and drive stronger outcomes. Working across more than 20 offices globally, our 1,750+ lawyers act on data-driven insights, deep relationships, and unmatched industry experience to deliver on our commitment of Always Better.

COVERAGE / DEAL ANNOUNCEMENT
October 23, 2025
Read time: 2 min
“Launched in early 2024, Marseille-based biotech company Adcytherix has raised a record €105 million from a consortium of French and international investors, including Bpifrance and the Andera Partners and Kurma Partners funds. The company aims to position itself at the forefront of the antibody-drug conjugate (ADC) market.”
Read the full article detailing the deal supported by McDermott’s life sciences and tax team.

COVERAGE
October 22, 2025
Read time: 2 min

COVERAGE
October 21, 2025
Read time: 2 min

COVERAGE
October 21, 2025
Read time: 2 min

COVERAGE
October 20, 2025
Read time: 2 min
Aymen Mahmoud, partner and European head of finance, was quoted in Mergermarket regarding a significant transformation occurring in the European leveraged finance market, moving more towards private credit. Initially implemented as a temporary solution during the bond market freeze of 2022, this shift is now evolving into a more permanent change.

COVERAGE
October 17, 2025
Read time: 2 min